Morgan Stanley’s TELA Bio TELA Stock Holding History
Bought
Maintained
Sold
Other funds holding TELA
EWM
NCM
SCM
SCM
VCM
DCM
PCM
SCM
Morgan Stanley's TELA Position: Q1 2026 in Review
Morgan Stanley sold out of TELA Bio (TELA) in Q1 2026, closing a stake of 2,219 shares — an estimated $2.62K sold.
Morgan Stanley first reported a position in TELA in Q1 2020 and held it in 23 quarters. The position peaked at $1.19M in Q4 2023. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.
- Morgan Stanley reported no remaining TELA Bio position as of Q1 2026 after selling out during the quarter.
- Morgan Stanley sold 2,219 TELA Bio shares in Q1 2026, an estimated $2.62K.
- Morgan Stanley first reported a position in TELA Bio in Q1 2020 and held it in 23 quarters.
- Morgan Stanley's TELA Bio position peaked at $1.19M in Q4 2023.
- 36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.